Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: A randomized double-blind study

被引:302
作者
Valtonen, S
Timonen, U
Toivanen, P
Kalimo, H
Kivipelto, L
Heiskanen, O
Unsgaard, G
Kuurne, T
机构
[1] TURKU UNIV,CENT HOSP,DEPT PATHOL,TURKU 20520,FINLAND
[2] UNIV HELSINKI,CENT HOSP,DEPT NEUROSURG,HELSINKI,FINLAND
[3] TAMPERE UNIV HOSP,DEPT NEUROSURG,TAMPERE,FINLAND
[4] UNIV TRONDHEIM HOSP,DEPT NEUROSURG,TRONDHEIM,NORWAY
[5] ORION PHARMA,ESPOO,FINLAND
关键词
BCNU; biodegradable polymer; chemotherapy; malignant glioma;
D O I
10.1097/00006123-199707000-00011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: To find out the effect of carmustine (bischloroethyl-nitrosourea) combined with a biodegradable polymer in the treatment of malignant (Grades III and IV) gliomas, applied locally, at the time of the primary operation. METHODS: Prospective, randomized double-blind study of an active treatment group versus a placebo group. Conducted at the Departments of Neurosurgery of the University Hospitals of Helsinki, Tampere, and Turku in Finland and Trondheim in Norway. The study consisted of 32 patients (16 in each treatment group) enrolled between March 23, 1992, and March 19, 1993. The study was planned to include 100 patients but had to be terminated prematurely, because the drug that was being used had become unobtainable. The main outcome measures included the survival times of patients after the operations and the application of an active drug or placebo. RESULTS: The median time from surgery to death was 58.1 weeks for the active treatment group versus 39.9 weeks for the placebo group (P = 0.012). For 27 patients with Grade IV tumors, the corresponding times were 39.9 weeks for the placebo group and 53.3 weeks for the active treatment group (P = 0.008). At the end of the study, six patients were still alive, five of whom belonged to the active treatment group. CONCLUSION: Carmustine applied locally in a biodegradable polymer at the time of primary operation, seems to have a favorable effect on the life span of patients with high-grade gliomas.
引用
收藏
页码:44 / 48
页数:5
相关论文
共 12 条
[1]   MEDICAL PROGRESS - BRAIN-TUMORS .1. [J].
BLACK, PM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (21) :1471-1476
[2]   The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: Phase I trial [J].
Brem, H ;
Ewend, MG ;
Piantadosi, S ;
Greenhoot, J ;
Burger, PC ;
Sisti, M .
JOURNAL OF NEURO-ONCOLOGY, 1995, 26 (02) :111-123
[3]   INTERSTITIAL CHEMOTHERAPY WITH DRUG POLYMER IMPLANTS FOR THE TREATMENT OF RECURRENT GLIOMAS [J].
BREM, H ;
MAHALEY, S ;
VICK, NA ;
BLACK, KL ;
SCHOLD, SC ;
BURGER, PC ;
FRIEDMAN, AH ;
CIRIC, IS ;
ELLER, TW ;
COZZENS, JW ;
KENEALY, JN .
JOURNAL OF NEUROSURGERY, 1991, 74 (03) :441-446
[4]   PLACEBO-CONTROLLED TRIAL OF SAFETY AND EFFICACY OF INTRAOPERATIVE CONTROLLED DELIVERY BY BIODEGRADABLE POLYMERS OF CHEMOTHERAPY FOR RECURRENT GLIOMAS [J].
BREM, H ;
PIANTADOSI, S ;
BURGER, PC ;
WALKER, M ;
SELKER, R ;
VICK, NA ;
BLACK, K ;
SISTI, M ;
BREM, S ;
MOHR, G ;
MULLER, P ;
MORAWETZ, R ;
SCHOLD, SC .
LANCET, 1995, 345 (8956) :1008-1012
[5]  
COLLETT D, 1994, MODELLING SURVIVAL D, P80
[6]   POSTOPERATIVE INTRACAVITARY CHEMOTHERAPY OF MALIGNANT GLIOMAS - PRELIMINARY STUDY USING METHOTREXATE [J].
GARFIELD, J ;
DAYAN, AD .
JOURNAL OF NEUROSURGERY, 1973, 39 (03) :315-322
[7]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[8]   CHEMOTHERAPY FOR MALIGNANT GLIOMAS [J].
KORNBLITH, PL ;
WALKER, M .
JOURNAL OF NEUROSURGERY, 1988, 68 (01) :1-17
[9]   THE CHEMOTHERAPY OF ADULT PRIMARY BRAIN-TUMORS [J].
LESSER, GJ ;
GROSSMAN, SA .
CANCER TREATMENT REVIEWS, 1993, 19 (03) :261-281
[10]  
TAMARGO RJ, 1993, CANCER RES, V53, P329